CDC director fixes coronavirus vaccine plan for health care workers, long-term care residents


The director of the Centers for Disease Control and Prevention (CDC), Dr. Robert Redfield has endorsed a vote by a panel of independent experts that health care workers and residents of long-term care facilities should be the first to wait a long time. Coronavirus vaccine.

“Dr. Redfield has endorsed his recommendations and signed the memo and accepted these interim recommendations.

Live updates: Today’s latest agreed-19 titles

Dr. Director of the Centers for Disease Control and Prevention.  Robert Redfield has signed a memo supporting the panel's recommendations on vaccine distribution.  (AP by Taso Catopodis / Pool)

The director of the Centers for Disease Control and Prevention, Dr. Robert Redfield has signed a memo supporting the panel’s recommendations on vaccine distribution. (AP by Taso Catopodis / Pool)

The CDC director also “looks forward” to further recommendations, hinging on the availability of vaccines that the U.S. should give preference to older adults over 70 who live in multi-generation homes. These homes pose a “significant risk” to “Hispanic, Black and tribal families” caring for the elderly, the statement said.

“In addition to this structure [Advisory Committee on Immunization Practices] The ACIP guidance will ensure more appropriate distribution to those who are hospitalized and at risk of death, ”the statement said.

The panel vote was 13-1 on Tuesday evening.

CDC’s new coronavirus quarantine guidance ‘strikes balance’ with reserving public, experts say

In addition to Redfield’s approval, the U.S. plans to distribute the vaccine to health care workers and long-term care residents. Based on the authorization of the Food and Drug Administration (FDA), which still has to approve the application for emergency use of the pharmaceutical giant Pfizer, the first to implement and the biotech company Moderna. Both companies have developed coronavirus vaccine candidates that have proven more than 90% effective in late-stage clinical trials.

“If the Food and Drug Administration (FDA) approves or approves a COVID-19 vaccine, the ACIP will quickly hold a public meeting to review all available data about that vaccine,” the CDC’s webpage, updated Thursday, reads. “From these data, ACIP will then vote on whether to recommend the vaccine, and if so, who should receive it.”

The report was contributed by Mad Dalen Farber of Fox News.